MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures

Naoto Muraoka1, Hiroyuki Yamakawa1, Kazutaka Miyamoto1

  • 1Department of Clinical and Molecular Cardiovascular Research, Keio University School of Medicine, Shinjuku-ku Tokyo, Japan Department of Cardiology, Keio University School of Medicine, Shinjuku-ku Tokyo, Japan.

The EMBO Journal
|June 13, 2014
PubMed

Related Concept Videos